InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the detailed record of transactions filed by Gangloff Scott A., 首席技术官. Director active across 1 company, notably Akero Therapeutics, Inc.. In total, 6 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €41k. Activity tracked since 16 December 2024. The latest transaction was disclosed on 15 August 2025 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Gangloff Scott A.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报6 总计
5,088 股Common StockSEC:0001193125-25-312111:0
21,263 股Common StockSEC:0001193125-25-312111:1
2,600 股@ US$19.62100.0% 占其流量Common StockSEC:0000950170-25-110352:0
299 股@ US$23.8686.7% 占其流量Common StockSEC:0000950170-25-093317:0
848 股@ US$54.8448.1% 占其流量Common StockSEC:0000950170-25-088640:0
24,300 股0Common StockSEC:0000950170-24-138138:0
6 条申报中的 6 条
About Gangloff Scott A.
Scott A. Gangloff is the Chief Technology Officer at Akero Therapeutics, Inc. He oversees the company's technological initiatives, ensuring innovation and process efficiency. His role is crucial for the development of new therapeutic solutions.
